Pfizer Inc Company Profile, Facts | Competitive Intelligence Report –


Pune, Maharashtra, India, September 21 2022 (Wiredrelease) Prudour Pvt. Ltd –:Pfizer Inc. is a pharmaceutical powerhouse that has been in operation for over 150 years. The company has developed and manufactured some of the most innovative and lifesaving medicines in the world. Pfizer products are available in more than 150 countries, making it a truly global player in the pharmaceutical industry. Pfizer’s products touch the lives of millions of people around the world, and the company is committed to improving the lives of its patients through its innovative products and services. Pfizer Inc. is a global leader in the pharmaceutical industry and its products have helped improve the lives of millions of people around the world. Its products include Lipitor (atorvastatin), Viagra (sildenafil), Celebrex (celecoxib), Lyrica (pregabalin) and Zoloft (sertraline).

It offers contract manufacturing services, sterile injectable pharmaceuticals, biosimilars, active pharmaceutical ingredients (APIs) and sterile injectable pharmaceuticals. Pfizer sells its products through wholesalers and retailers, hospitals, clinics as well as government agencies, pharmacies and clinics. It has manufacturing facilities in India and China as well as Germany, Singapore, Singapore, Italy, Belgium and Germany. It sells its products in North and South America, Asia-Pacific as well as Australia, Europe, Africa and the Middle East. Pfizer’s headquarters are located in New York, USA.

Financial overview

The company has a strong financial position, with revenues of $52.5 billion in 2016 and $48.8 billion in 2017. Net income was $10.4 billion in 2016 and $12.6 billion in 2017. Total assets were $191 billion in 2016 and $205 billion in 2017. Total equity was $70 billion in 2016 and $79 billion in 2017. The share price Pfizer Inc.’s stock price has been on a gradual upward trend over the past five years, rising from around $20 per share in 2013 to its current level of around $36 per share.

Place an order direct from Pfizer Inc company profile @

Key financial data
Revenue (M$ US)

– Pfizer Inc. generated annual revenue of US$81,288 million in 2021

– Pfizer Inc.’s 2020 annual revenue was US$41.908 million. This is a decrease of -19.02% compared to 2019.

– Pfizer Inc reported a -3.54% decline in annual revenue from 2018 to 2019, which amounted to US$51.750 million

– Pfizer Inc. generated total revenue of US$53,647 million in 2018.

Browse Full Pfizer Inc Company Profile Summary @

Operating income (US$ million)

– Pfizer Inc.’s operating income in 2021 was US$22,235 million. This is an increase of 130.99% over 2020.

– Pfizer Inc’s operating profit in 2020 was US$8,760 million

– Pfizer Inc operating profit of US$13,921 million, down -7.47%, indexed in 2019.

– Pfizer Inc made 2018 operating profit of US$15,045 million

Recent Developments/News

Pfizer Inc has recently made headlines for its involvement in the development of a coronavirus vaccine. The company is working with German biotech company BioNTech to develop the vaccine. Clinical trials of the vaccine are currently underway. If the vaccine is successful, it could be available by the end of 2020. Pfizer Inc is also working to develop other potential treatments for the coronavirus, including an antiviral drug and a monoclonal antibody treatment.

Explore more company profiles:

General Dynamics Corporation Company Profile Report:

Northrop Grumman Corporation Company Profile Strategic Moves and Competitive Intelligence Report –

Profile and news of Thales SA –

This content was posted by Prudour Pvt. company ltd. WiredRelease’s news service was not involved in the creation of this content. For press release service inquiries, please contact us at [email protected]


Comments are closed.